Gannex Pharma
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Free Trade Zone No. 665 F Pilot, Shangha...Website
www.gannexpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Gannex Pharma
Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. (1672.HK), is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical stage drug candidates against three different targets — FASN, THR-β and FXR — and three combination therapies.Explore more
Popular SearchesGannex Pharma Co. LtdGannex Pharma Co LtdSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gannex Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Gannex Pharma has new funding data
Click to see if Gannex Pharma had a recent Job posting/layoffs
Gannex Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Gannex Pharma is spiking on competitors!
Check if Gannex Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gannex Pharma
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Gannex Pharma recently announced quarterly report
Product Launch: Get notified when Gannex Pharma launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Gannex Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gannex Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gannex Pharma.
Gannex Pharma News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gannex Pharma
Sign Up For FreeTo access detailed company insights
Founded in 2019, Gannex, a wholly-owned company of Ascletis Pharma Inc. (1672.HK), is dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical stage drug candidates against three different targets — FASN, THR-β and FXR — and three combination therapies.... Read More
